Novotech Revenue and Competitors

Headquartered in Sydney, Australia and focused exclusively on the Asia Pacific, Novotech is internationally recognized as a leading regional full-service CRO. With the increasing pace of globalization in drug development, Novotech's expertise in the vibrant and fast growing Asian region was instrumental in the success of hundreds of phase I-IV clinical trials. With operations in Australia, New Zealand, South Africa, Hong Kong, China, India, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand, Novotech's service offering is recognized for its quality by our clients and industry analyst groups. Our History Established in 1996, Novotech is Australia's largest independent CRO. The Australian Head Office is in Sydney, with regional offices in Melbourne and Brisbane - providing easy access to the most important population centers in Australia. Supported by regional staff across the country and in New Zealand, our coverage of the Australia/New Zealand region is comprehensive. With Asian services launched in 2007, Novotech's operations provide access to the most dynamic and fast growing clinical research hubs in the region. In addition, we offer worldwide reach to our clients through key partnerships and strategic alliances, with partners in the US, Canada, Europe, and China. The combination of a relatively small, flexible CRO, coupled with the ability to confidently manage very large projects allows us to move a project from initial planning stage to recruitment with dramatic speed.